Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02441920Terminated

Chronic Periodontitis and Tooth Loss in Patients With Rheumatoid Arthritis

Role: collaborator

NCT04997811Phase 2Unknown

Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Role: collaborator

NCT02791633Completed

Recovery After Emergency Laparotomy: a Prospective Observational Feasibility Study

Role: lead

NCT02408107Phase 3Completed

A Home-based Physical Activity Intervention in Breast Cancer Survivors

Role: lead

All 4 trials loaded